This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "may," "will," "might," "expect," "believe," "anticipate," "could," "would," "should," "estimate," "continue," "pursue," or the negative thereof or comparable terminology, and may include without limitation information regarding the Company's expectations, goals or intentions regarding the future, including without limitation statements regarding expectations of full-year outlook, anticipated recurring revenue growth, expectations of new product offerings, the anticipated closing and expected effect on earnings results of the Company's expected acquisition of the lab-based diagnostics business of Olympus Corporation, expense management and profitability, achievement of our goals, and statements under the heading "Full Year Outlook," including expectations for constant currency recurring revenue gains, reported revenue growth, operating margin, currency exchange rates, pension expense, adjusted non-operating expense, cost management initiatives, hedging activities, tax rate, earnings per diluted share, capital expenditures, and depreciation and amortization. The outlook provided is based on fiscal year ended 2008 and the first quarter 2009 adjusted results and does not include special items that may occur in 2009.
This press release contains the Company's unaudited financial results for the first quarter of 2009. These results may change as a result of further review by the Company's independent accountants and management. The completion of the review of our financial statements could result in additional changes to our financial results and could result in the identification of issues relating to the effectiveness of our internal control over financial reporting. Final
|SOURCE Beckman Coulter, Inc.|
Copyright©2009 PR Newswire.
All rights reserved